GITLAB INC-CL A (GTLB)

US37637K1088 - Common Stock

59.83  +4.17 (+7.49%)

After market: 60.3 +0.47 (+0.79%)

Fundamental Rating

5

GTLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. No worries on liquidiy or solvency for GTLB as it has an excellent financial health rating, but there are worries on the profitability. GTLB shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

GTLB had positive earnings in the past year.
In the past year GTLB has reported a negative cash flow from operations.
In the past 5 years GTLB always reported negative net income.
In the past 5 years GTLB reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.88%, GTLB is in line with its industry, outperforming 50.54% of the companies in the same industry.
The Return On Equity of GTLB (-6.71%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.88%
ROE -6.71%
ROIC N/A
ROA(3y)-20.38%
ROA(5y)-29.5%
ROE(3y)-38.88%
ROE(5y)-52.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 89.00%, GTLB belongs to the top of the industry, outperforming 94.62% of the companies in the same industry.
In the last couple of years the Gross Margin of GTLB has remained more or less at the same level.
GTLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

GTLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GTLB has more shares outstanding
There is no outstanding debt for GTLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 10.59 indicates that GTLB is not in any danger for bankruptcy at the moment.
The Altman-Z score of GTLB (10.59) is better than 81.36% of its industry peers.
There is no outstanding debt for GTLB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.59
ROIC/WACCN/A
WACC11.91%

2.3 Liquidity

GTLB has a Current Ratio of 2.57. This indicates that GTLB is financially healthy and has no problem in meeting its short term obligations.
GTLB has a Current ratio of 2.57. This is in the better half of the industry: GTLB outperforms 70.25% of its industry peers.
A Quick Ratio of 2.57 indicates that GTLB has no problem at all paying its short term obligations.
GTLB's Quick ratio of 2.57 is fine compared to the rest of the industry. GTLB outperforms 70.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 5500.00% over the past year.
GTLB shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.01%.
Measured over the past years, GTLB shows a very strong growth in Revenue. The Revenue has been growing by 56.19% on average per year.
EPS 1Y (TTM)5500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.56%
Revenue 1Y (TTM)32.01%
Revenue growth 3Y56.19%
Revenue growth 5YN/A
Sales Q2Q%30.99%

3.2 Future

GTLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.10% yearly.
Based on estimates for the next years, GTLB will show a very strong growth in Revenue. The Revenue will grow by 23.26% on average per year.
EPS Next Y239.68%
EPS Next 2Y105.65%
EPS Next 3Y75.49%
EPS Next 5Y46.1%
Revenue Next Year31.25%
Revenue Next 2Y27.87%
Revenue Next 3Y26.25%
Revenue Next 5Y23.26%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 106.84, the valuation of GTLB can be described as expensive.
GTLB's Price/Earnings ratio is in line with the industry average.
GTLB is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 74.46 indicates a quite expensive valuation of GTLB.
GTLB's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.73, GTLB is valued quite expensively.
Industry RankSector Rank
PE 106.84
Fwd PE 74.46

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GTLB's earnings are expected to grow with 75.49% in the coming years.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y105.65%
EPS Next 3Y75.49%

0

5. Dividend

5.1 Amount

GTLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GITLAB INC-CL A

NASDAQ:GTLB (12/20/2024, 8:15:54 PM)

After market: 60.3 +0.47 (+0.79%)

59.83

+4.17 (+7.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners80.67%
Inst Owner Change4.51%
Ins Owners3.18%
Ins Owner Change3.52%
Market Cap9.71B
Analysts82.35
Price Target68.92 (15.19%)
Short Float %3.55%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.78%
Min EPS beat(2)45.64%
Max EPS beat(2)47.93%
EPS beat(4)4
Avg EPS beat(4)87.08%
Min EPS beat(4)45.64%
Max EPS beat(4)177.48%
EPS beat(8)8
Avg EPS beat(8)218.69%
EPS beat(12)12
Avg EPS beat(12)157.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.75%
Min Revenue beat(2)1.19%
Max Revenue beat(2)2.31%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)2.31%
Revenue beat(8)7
Avg Revenue beat(8)2.56%
Revenue beat(12)11
Avg Revenue beat(12)4.09%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)4.73%
EPS NQ rev (1m)11.68%
EPS NQ rev (3m)11.68%
EPS NY rev (1m)35.14%
EPS NY rev (3m)35.29%
Revenue NQ rev (1m)1.16%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)1.36%
Valuation
Industry RankSector Rank
PE 106.84
Fwd PE 74.46
P/S 13.65
P/FCF N/A
P/OCF N/A
P/B 13.4
P/tB 14.09
EV/EBITDA N/A
EPS(TTM)0.56
EY0.94%
EPS(NY)0.8
Fwd EY1.34%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS4.38
BVpS4.47
TBVpS4.25
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.88%
ROE -6.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89%
FCFM N/A
ROA(3y)-20.38%
ROA(5y)-29.5%
ROE(3y)-38.88%
ROE(5y)-52.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.81%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 10.59
F-Score4
WACC11.91%
ROIC/WACCN/A
Cap/Depr(3y)141.87%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.04%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%155.56%
EPS Next Y239.68%
EPS Next 2Y105.65%
EPS Next 3Y75.49%
EPS Next 5Y46.1%
Revenue 1Y (TTM)32.01%
Revenue growth 3Y56.19%
Revenue growth 5YN/A
Sales Q2Q%30.99%
Revenue Next Year31.25%
Revenue Next 2Y27.87%
Revenue Next 3Y26.25%
Revenue Next 5Y23.26%
EBIT growth 1Y18.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year804.88%
EBIT Next 3Y178.89%
EBIT Next 5Y101.29%
FCF growth 1Y-39.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.25%
OCF growth 3YN/A
OCF growth 5YN/A